Financials data is unavailable for this security.
View more
Year on year Tri Chemical Laboratories Inc 's revenues fell -18.53% from 13.80bn to 11.25bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 4.83bn to 2.47bn, a -48.87% decrease.
| Gross margin | 37.75% |
|---|---|
| Net profit margin | 22.42% |
| Operating margin | 20.49% |
| Return on assets | 9.33% |
|---|---|
| Return on equity | 11.04% |
| Return on investment | 10.36% |
More ▼
Cash flow in JPYView more
In 2024, cash reserves at Tri Chemical Laboratories Inc fell by 640.46m. However, the company earned 2.97bn from its operations for a Cash Flow Margin of 26.43%. In addition the company used 1.78bn on investing activities and also paid 1.86bn in financing cash flows.
| Cash flow per share | 135.01 |
|---|---|
| Price/Cash flow per share | 25.22 |
| Book value per share | 885.41 |
|---|---|
| Tangible book value per share | 882.79 |
More ▼
Balance sheet in JPYView more
| Current ratio | 6.09 |
|---|---|
| Quick ratio | 4.72 |
| Total debt/total equity | 0.0602 |
|---|---|
| Total debt/total capital | 0.0568 |
More ▼
Growth rates in JPY
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -48.87%. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
| Div yield(5 year avg) | 0.74% |
|---|---|
| Div growth rate (5 year) | 21.67% |
| Payout ratio (TTM) | 31.98% |
| EPS growth(5 years) | 0.9387 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -14.89 |
More ▼
